ABBVIE

{
  "facts": [
    {
      "type": "filing",
      "quote": "23 AVR. 2026",
      "value": "2026-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "07/05/2026",
      "value": "2026-05-07",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de Rolfe van de Spreng \u00E0 compter du 1er avril 2026",
      "value": {
        "date": "2026-04-01",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "officer_appointment",
      "quote": "L\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer Erica Silbiger ... en qualit\u00E9 de nouvel administrateur de la Soci\u00E9t\u00E9, avec effet au 1er avril 2026",
      "value": {
        "date": "2026-04-01",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "mandate_compensation",
      "quote": "Son mandat ne sera pas r\u00E9mun\u00E9r\u00E9",
      "value": {
        "amount": 0,
        "currency": "EUR"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "mandate_term",
      "quote": "prendra fin imm\u00E9diatement lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se tiendra en 2028",
      "value": {
        "end_condition": "assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se tiendra en 2028"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "representation_rule",
      "quote": "la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e \u00E0 l\u0027\u00E9gard des tiers et en justice par le conseil d\u0027administration ou par deux administrateurs agissant conjointement",
      "value": {
        "rule": "le conseil d\u0027administration ou par deux administrateurs agissant conjointement"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "representation_rule",
      "quote": "Dans les limites de la gestion journali\u00E8re, la Soci\u00E9t\u00E9 est \u00E9galement repr\u00E9sent\u00E9e par la personne \u00E0 qui cette gestion journali\u00E8re a \u00E9t\u00E9 d\u00E9l\u00E9gu\u00E9e",
      "value": {
        "rule": "la personne \u00E0 qui cette gestion journali\u00E8re a \u00E9t\u00E9 d\u00E9l\u00E9gu\u00E9e"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "l\u0027actionnaire unique a charg\u00E9 Nathalie Boonen ... de la signature des formulaires I, II et de tout autre document n\u00E9cessaire en vue du d\u00E9p\u00F4t et de la publication de la d\u00E9cision prise ci-dessus dans les annexes du Moniteur belge",
      "value": {
        "date": "2026-04-01",
        "scope": "signature des formulaires I, II et de tout autre document n\u00E9cessaire en vue du d\u00E9p\u00F4t et de la publication"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "power_of_attorney",
      "quote": "l\u0027actionnaire unique a charg\u00E9 ... Jean-Fran\u00E7ois Mouchet ... chacun agissant individuellement, de la signature des formulaires I, II et de tout autre document n\u00E9cessaire en vue du d\u00E9p\u00F4t et de la publication de la d\u00E9cision prise ci-dessus dans les annexes du Moniteur belge",
      "value": {
        "date": "2026-04-01",
        "scope": "signature des formulaires I, II et de tout autre document n\u00E9cessaire en vue du d\u00E9p\u00F4t et de la publication"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: D\u00E9mission et nomination d\u0027un administrateur",
      "value": "D\u00E9mission et nomination d\u0027un administrateur",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 2045,
    "truncated": false,
    "needs_verify": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "Abbvie",
      "attrs": {
        "seat": "Avenue Einstein 14, 1300 Wavre",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Rolfe van de Spreng",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Erica Silbiger",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Nathalie Boonen",
      "attrs": {
        "employer": "PwC Business Advisory Services SRL"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Fran\u00E7ois Mouchet",
      "attrs": {
        "employer": "PwC Legal SRL"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean-Antoine de Los Frailes",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-12-01",
      "evidence_quote": "Il ressort des r\u00E9solutions prises par l\u0027actionnaire unique en date du 9 d\u00E9cembre 2025 que l\u0027actionnaire unique a d\u00E9cid\u00E9 d\u0027accepter la d\u00E9mission de M. Jean-Antoine de Los Frailes \u00E0 compter du 1ier d\u00E9cembre 2025."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Rolfe van de Spreng",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-12-01",
      "evidence_quote": "L\u0027actionnaire unique a nomm\u00E9 Rolfe van de Spreng, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en qualit\u00E9 de nouvel administrateur de la Soci\u00E9t\u00E9, avec effet au 1ier d\u00E9cembre 2025."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Thomas Meurice",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Il ressort des r\u00E9solutions \u00E9crites de l\u0027actionnaire unique, prises le 30 mai 2025, que l\u0027actionnaire unique \u00E0 d\u00E9cid\u00E9 de renouveler la nomination de la soci\u00E9t\u00E9 \u00AB EY R\u00E9viseurs d\u0027Entreprises SRL \u00BB, (\u041200160), ayant son si\u00E8ge \u00E0 Kouterveldstraat 7B, 1831 Diegem, comme Commissaire de la Soci\u00E9t\u00E9 pour un ter"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2024-08-23",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 23/08/2024",
      "value": "23/08/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 19 JUNI 2024 ter griffie van de Nederlandstalige ondernemingsrechtbank Brussel",
      "value": "19/06/2024",
      "object": null,
      "subject": "e1",
      "date_suspect": "2024-06-19"
    },
    {
      "date": "2024-03-13",
      "type": "general_meeting",
      "quote": "BUITENGEWONE ALGEMENE VERGADERING VAN 13 MAART 2024",
      "value": "13/03/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 15 MEI 2024",
      "value": "15/05/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-03-13",
      "type": "officer_appointment",
      "quote": "Benoeming van: Bayer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AbbVie N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Eli Lilly Benelux N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Pfizer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4.GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Takeda Belgium N.V.",
      "value": {
        "date": "2024-03-13",
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "13/03/2024",
        "role": "bestuurder"
      }
    },
    {
      "date": "2024-05-15",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 15 mei 2024 werd mevrouw An Van Gerven tot ondervoorzitter van de Raad van Bestuur benoemd.",
      "value": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "start_date": "2024-05-15"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "term": null,
        "start_date": "15/05/2024"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Bayer N.V. (BE 0404.754.571) heeft als vaste vertegenwoordiger de heer Werner De Prins.",
      "value": null,
      "object": "e2",
      "subject": "e12"
    },
    {
      "date": "2024-05-24",
      "type": "permanent_representative",
      "quote": "Sanofi Belgium N.V. (BE 0464.435.901) heeft als nieuwe vaste vertegenwoordiger vanaf 24/05/2024 de heer Bart Vermeulen in opvolging van de heer Johan Heylen.",
      "value": {
        "start_date": "24/05/2024"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2024-06-14",
      "type": "permanent_representative",
      "quote": "Bayer N.V. (BE 0404.754.571) heeft als nieuwe vaste vertegenwoordiger vanaf 14/06/2024 de heer Niels Hessmann in opvolging van de heer Werner De Prins.",
      "value": {
        "start_date": "14/06/2024"
      },
      "object": "e2",
      "subject": "e13"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Buitengewone Algemene Vergadering van 13 maart 2024",
      "value": null,
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2024-06-19 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 27430,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0404.754.571",
      "kind": "company",
      "name": "Bayer N.V.",
      "attrs": {
        "seat": "J.E. Mommaertslaan 14, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie N.V.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux N.V.",
      "attrs": {
        "seat": "Markiesstraat 1, 1000 Brussel"
      }
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {
        "seat": "Pleinlaan 17, 1050 Elsene"
      }
    },
    {
      "id": "e6",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Fleming 20, 1300 Wavre"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Bart Vermeulen",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Johan Heylen",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Werner De Prins",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Niels Hessmann",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination administrateurs - nomination vice-pr\u00E9sidente Conseil d\u0027administration - modifications aux statuts - nouveaux repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination administrateurs - nomination vice-pr\u00E9sidente Conseil d\u0027administration - modifications aux statuts - nouveaux repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-08-23",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 23/08/2024 - Annexes du Moniteur belge",
      "value": "23/08/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 19 JUNI 2024",
      "value": "19/06/2024",
      "object": null,
      "subject": "e1",
      "date_suspect": "2024-06-19"
    },
    {
      "date": "2024-03-13",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 13 MARS 2024",
      "value": "13/03/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-03-13",
      "type": "officer_appointment",
      "quote": "Nomination de : Bayer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 2. Eli Lilly Benelux S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 3. Pfizer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 4.GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Takeda Belgium S.A.",
      "value": {
        "date": "2024-03-13",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "13/03/2024",
        "role": "administrateur"
      }
    },
    {
      "date": "2024-03-13",
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 13 mars 2024",
      "value": "Modifications aux statuts approuv\u00E9es par l\u0027AGE du 13 mars 2024 (articles 2, 5, 9, 12, 16, 28 et dispositions transitoires)",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 15 MAI 2024",
      "value": "15/05/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 15 mai 2024, Madame An Van Gerven a \u00E9t\u00E9 d\u00E9sign\u00E9e comme Vice-Pr\u00E9sidente.",
      "value": {
        "role": "Vice-Pr\u00E9sidente",
        "start_date": "2024-05-15"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sidente",
        "start_date": "15/05/2024"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Bayer S.A. (BE 0404.754.571) a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Wemer De Prins.",
      "value": {
        "start_date": null
      },
      "object": "e2",
      "subject": "e9"
    },
    {
      "date": "2024-05-24",
      "type": "permanent_representative",
      "quote": "Sanofi Belgium S.A. (BE 0464.435.901) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 24/05/2024 Monsieur Bart Vermeulen, succ\u00E9dant \u00E0 Monsieur Johan Heylen.",
      "value": {
        "start_date": "24/05/2024"
      },
      "object": "e10",
      "subject": "e11"
    },
    {
      "date": "2024-06-14",
      "type": "permanent_representative",
      "quote": "Bayer S.A. (BE 0404.754.571) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 14/06/2024 Monsieur Niels Hessmann, succ\u00E9dant \u00E0 Monsieur Werner De Prins.",
      "value": {
        "start_date": "14/06/2024"
      },
      "object": "e2",
      "subject": "e13"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2024-06-19 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 28008,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0404.754.571",
      "kind": "company",
      "name": "Bayer S.A.",
      "attrs": {
        "seat": "J..E. Mommaertslaan 14, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "Boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Fleming 20, 1300 Wavre"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Werner De Prins",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Bart Vermeulen",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Johan Heylen",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Niels Hessmann",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Renaud Decroix",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Il ressort des d\u00E9cisions \u00E9crites de l\u0027actionnaire unique prises en date du 31 mai 2024 que l\u0027actionnaire unique a d\u00E9cid\u00E9 de renouveler le mandat de Renaud Decroix en tant qu\u0027administrateur d\u00E9l\u00E9gu\u00E9 et Pr\u00E9sident du Conseil d\u0027administration de la soci\u00E9t\u00E9 jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale de 2027."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Meike Kerstens",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-04-12",
      "evidence_quote": "II ressort des r\u00E9solutions \u00E9crites de l\u0027actionnaire unique prises le 27 mars 2024 que l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de Madame Meike Kerstens comme administrateur de ia Soci\u00E9t\u00E9 \u00E0 partir du 12 avril 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Il ressort des d\u00E9cisions \u00E9crites de l\u0027actionnaire unique prises en date du 30 mai 2022 que l\u0027actionnaire unique a d\u00E9cid\u00E9 de renouveller le mandat du commissaire, EY R\u00E9viseurs d\u0027Entreprises, pour les 3 ann\u00E9es 2022, 2023 et 2024."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Antoine De Los Frailes",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Il ressort des d\u00E9cisions \u00E9crites de l\u0027actionnaire unique prises en date du 26 mai 2023 que l\u0027actionnaire unique a d\u00E9cid\u00E9 de renouveller le mandat d\u0027administrateur de Monsieur Jean Antoine De Los Frailes et c\u0441eci jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale \u00E0 tenir en 2026."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Renaud Decroix",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Wavre",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-03-10",
    "filing_date": "2022-03-02",
    "act_kind_objet": "Projet de fusion"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-02-28",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0845.096.860",
        "name": "AbbVie SA",
        "role": "acquiring",
        "address": "Avenue Einstein 14, 1300 Wavre",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0435.972.933",
        "name": "Allergan NV",
        "role": "absorbed",
        "address": "De Kleetlaan 4, 1831 Machelen",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "12:7",
      "12:13"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": true,
    "patrimony_description": "L\u0027op\u00E9ration consiste en le transfert int\u00E9gral, sans r\u00E9serve ni exception, de l\u0027ensemble du patrimoine actif et passif de Allergan NV \u00E0 AbbVie SA. Cela inclut tous les actifs, passifs, droits et obligations li\u00E9s \u00E0 l\u0027activit\u00E9 pharmaceutique, m\u00E9dicale, chimique et biologique, ainsi que les biens immobiliers et mobiliers associ\u00E9s.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2022-01-01"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "AbbVie",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Renaud Decroix",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le projet de fusion par absorption, pr\u00E9par\u00E9 par le conseil d\u0027administration d\u0027AbbVie SA et d\u0027Allergan NV, pr\u00E9voit le transfert int\u00E9gral du patrimoine de Allergan NV \u00E0 AbbVie SA, conform\u00E9ment aux articles 12:50 et suivants du Code des soci\u00E9t\u00E9s et des associations. \u00C9tant donn\u00E9 que AbbVie est actionnaire unique de Allergan, l\u0027op\u00E9ration est assimil\u00E9e \u00E0 une fusion silencieuse. L\u0027op\u00E9ration sera soumise \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales extraordinaires des actionnaires des deux soci\u00E9t\u00E9s, pr\u00E9vues pour le 29 avril 2022.",
  "co_filed_documents": [
    "Projet de fusion"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 5909587.77,
      "currency": "EUR",
      "after_eur": 79163943.87,
      "delta_eur": 5909587.77,
      "before_eur": 73254356.1,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-12-07",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de cinq millions neuf cent et neuf mille cinq cent quatre-vingt-sept euros septante-sept cents (EUR 5.909.587,77), pour le porter de septante-trois millions deux cent cinquante-quatre mille trois cent cinquante-six euros dix cents (EUR 73.254.356,10) \u00E0 septante-neuf millions cent soixante-trois mille neuf cent quarante-trois euros quatre-vingt-sept cents (EUR 79.163.943,87), par la cr\u00E9ation d\u2019un million cinq cent quarante-sept mille neuf cent soixante (1.547.960) actions nouvelles, sans d\u00E9signation de valeur nominale, du m\u00EAme type et jouissant des m\u00EAmes droits et avantages que les actions existantes.",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op ... 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 17 MAART 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. Takeda Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AbbVie N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 2. Amgen N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 3. Eli Lilly Benelux N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 4. Pfizer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Merck N.V.",
      "value": {
        "role": "bestuurder",
        "end_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium NV heeft als vaste vertegenwoordiger de heer Laurerit Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    },
    {
      "type": "officer_appointment",
      "quote": "Caroline Ven CEO, belast met het dagelijks bestuur",
      "value": {
        "role": "CEO, belast met het dagelijks bestuur"
      },
      "object": "e1",
      "subject": "e9"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-04-23 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1820,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie N.V.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen N.V.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux N.V.",
      "attrs": {
        "seat": "Markiesstraat 1, 1000 Brussel"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {
        "seat": "Pleinlaan 17, 1050 Elsene"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "flag": "Name \u0027Laurerit\u0027 appears to be an OCR error for \u0027Laurent\u0027, but preserved as printed.",
      "kind": "person",
      "name": "Laurerit Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Brussel",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (Frankrijk)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, belast met het dagelijks bestuur"
      }
    }
  ]
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "1/2021",
      "value": "2021-01-01",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 17 MARS 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Nomination de: 1. Takeda Belgium S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Amgen S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "date": "2021-03-17",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 1. Merck S.A.",
      "value": {
        "date": "2021-03-17",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Laurent Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-01-01 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1896,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Laurent Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Bruxelles",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (France)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thibault Massart",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-07-31",
      "evidence_quote": "Il ressort des r\u00E9solutions unanimes \u00E9crites des actionnaires prises le 21 ao\u00FBt 2020 que les actionnaires ont d\u00E9cid\u00E9 d\u0027accepter la d\u00E9mission de Monsieur Thibault Massart en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9 \u00E0 partir du 31 juillet 2020."
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Thibault Massart",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-07-31",
      "evidence_quote": "Il ressort des r\u00E9solutions unanimes \u00E9crites des administrateurs en date du 7 septembre 2020 que, suite \u00E0 la d\u00E9mission de Monsieur Thibault Massart en tant qu\u0027administrateur les administrateurs ont constat\u00E9 \u00E9galement sa d\u00E9mission en tant qu\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9 \u00E0 partir du 31 juillet "
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Renaud Decroix",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-08-01",
      "evidence_quote": "Ensuite, les actionnaires ont d\u00E9cid\u00E9, en remplacement de Monsieur Thibault Massart, de nommer Monsieur Renaud Decroix, \u00E9lisant domicile au si\u00E8ge de la soci\u00E9t\u00E9, en qualit\u00E9 de nouvel administrateur \u00E0 partir du 1ler ao\u00FBt 2020 pur un terme de quatre ans."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Renaud Decroix",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-08-01",
      "evidence_quote": "Ensuite, conform\u00E9ment \u00E0 l\u0027article 20, b) des statuts et en remplacement de Morsieur Thibault Massart, les administrateurs ont d\u00E9cid\u00E9 de confier la gestion jourrali\u00E8re de la Soci\u00E9t\u00E9, ainsi que la repr\u00E9sentation de cette derni\u00E8re dans le cadre de cette gestion, \u00E0 Monsieur Renaud Decroix, administrateu"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2020-07-30",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Eric Van Hoof",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0845096860",
        "name": "Ernst \u0026 Young R\u00E9viseur\u0027s d\u0027Entreprises SC SCRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Les Actionnaires d\u00E9cident de r\u00E9\u00E9lire Ernst \u0026 Young R\u00E9viseur\u0027s d\u0027Entreprises SC SCRL, ayant son si\u00E8ge social De Kleetlaan 2, 1831 Diegem, repr\u00E9sent\u00E9e par M. Eric Van Hoof, r\u00E9viseur d\u0027entreprise, en tant que commissaire de la soci\u00E9t\u00E9 pour une dur\u00E9e de trois (3) ans"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "William Chase",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-03-29",
      "evidence_quote": "Les Actionnaires prennent note de, et acceptent pour autant que de besoin, la d\u00E9mission de M. William Chase de ses fonctions d\u0027administrateur de la Soci\u00E9t\u00E9, prenant effet au 29 mars 2019."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Robert Andrew Michael",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-03-29",
      "evidence_quote": "Les Actionna\u00EDres nomment M. Robert Andrew Michael, de nationalit\u00E9 am\u00E9ricaine r\u00E9sidant 321 Whitmore Lane, Lake Forest, IL60045, Etats-Unis d\u0027Am\u00E9rique, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 29: mars 2019 pour un terme prenant fin lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2018-07-09",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2018",
      "value": "09/07/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-06-20",
      "type": "filing",
      "quote": "neergelegd/onvangen od 20 JUM 2018",
      "value": "20/06/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-03-23",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 23 MARS 2018",
      "value": "23/03/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-03-23",
      "type": "officer_appointment",
      "quote": "Nomination de : 1. Amgen S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Celgene S.P.R.L.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Boehringer Ingelheim SCS",
      "value": {
        "date": "2018-03-23",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "23/03/2018",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2018-05-30",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 30 MAI 2018",
      "value": "30/05/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-05-30",
      "type": "officer_appointment",
      "quote": "Pfizer ... a \u00E9t\u00E9 \u00E9lue pr\u00E9sident ... pour un mandat de deux ans",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "2018-05-30"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "30/05/2018"
      }
    },
    {
      "date": "2018-05-30",
      "type": "officer_appointment",
      "quote": "MSD Belgium ... a \u00E9t\u00E9 \u00E9lue Vice-Pr\u00E9sident ... pour un mandat de deux ans",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "2018-05-30"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "30/05/2018"
      }
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1885,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene S.P.R.L.",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-l\u0027Alleud"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e7",
      "kbo": "0435.953.632",
      "kind": "company",
      "name": "Boehringer Ingelheim SCS",
      "attrs": {
        "seat": "avenue Ariane 16, 1200 Woluwe-Saint-Lambert"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "company",
      "name": "MSD Belgium",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Clarisse Lhoste",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Louis Gantmacher",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-08-31",
      "evidence_quote": "Les Actionnaires prennent note de et acceptent, pour autant que de besoin, la d\u00E9mission de M. Jean Louis Gantmacher de ses fonctions d\u0027administrateur de la Soci\u00E9t\u00E9, prenant effet au 31 ao\u00FBt 2017.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Antoine de Los Frailes",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-12-08",
      "evidence_quote": "Les Actionnaires d\u00E9cident de confirmer la nomination de M. Jean Antoine de Los Frailes, de nationalit\u00E9 fran\u00E7aise, r\u00E9sidant \u00E0 101 Rue Basse, 1180 Uccle, Belgique, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 8 d\u00E9cembre 2017 pour un terme de six (6) ans prenant fin lors de l\u0027assembl\u00E9e g\u00E9n\u00E9ra"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 21733989.0,
      "currency": "EUR",
      "after_eur": 73254356.1,
      "delta_eur": -21733989.0,
      "before_eur": 94988345.1,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2016-08-29",
      "evidence_quote": "de r\u00E9duire le capital social \u00E0 concurrence de vingt et un millions sept cent trente-trois mille neuf cent quatre-vingt-neuf euros (21.733.989,00 EUR), pour le ramener de nonante-quatre millions neuf cent quatre-vingt-huit mille trois cent quarante-cing euros dix cents (94.988.345,10 EUR) \u00E0 septante-trois millions deux cent cinquante-quatre mille trois cent cinquante-six euros dix cents (73.254.356,10 EUR).",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jaroslaw Oleszczuk",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-11",
      "evidence_quote": "Les Actionnaires prennent note de et acceptent, pour autant que de besoin, ia d\u00E9mission de M. Jaroslaw Oleszczuk de ses fonctions d\u0027Administrateur de la Soci\u00E9t\u00E9, prenant effet au 11 mai 2016."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thibault Massart",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-11",
      "evidence_quote": "Les Actionnaires d\u00E9cidert de confirmer la nomination de M. Thibault Massart, de nationalit\u00E9 belge, r\u00E9sidant Rue du Printemps 23, B-1380 Ohain, en tant qu\u0027Administrateur de la Soci\u00E9t\u00E9, avec effet au 11 mai 2016 pour un terme prenant fin lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires statuant"
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Jaroslaw Oleszczuk",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-11",
      "evidence_quote": "Le Conseil d\u0027Administration prend note de et accepte, pour autant que de beso\u00EDn, la d\u00E9mission de M. Jaroslaw Oleszczuk de ses fonctions d\u0027Administrateur D\u00E9l\u00E9gu\u00E9 et de Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9, prenant effet au 11 mal 2016."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Thibault Massart",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2016-05-11",
      "evidence_quote": "Le Conseil d\u0027Administration confirme par coris\u00E9quent que M. Jaroslaw Oleszczuk est remplac\u00E9 par M. Thibault Massart, de nationalit\u00E9 belge, r\u00E9sidant Rue du Printemps 23, B-1380 Ohain, en qualit\u00E9 d\u0027Administrateur D\u00E9l\u00E9gu\u00E9 et de Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9, avec effet au 11 mai 2"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Jaros\u0142aw Oleszczuk",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Wavre",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2015-06-15",
    "filing_date": "2015-06-02",
    "act_kind_objet": "Octroi de pouvoirs en mati\u00E8re de ressources humaines"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2015-05-22",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0845.096.860",
        "name": "AbbVie",
        "role": "other",
        "address": "Avenue Einstein 14, 1300 Wavre, Belgique",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:103"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Aucun patrimoine n\u0027est transf\u00E9r\u00E9. L\u0027acte concerne l\u0027octroi de pouvoirs sp\u00E9cifiques en mati\u00E8re de ressources humaines.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "AbbVie",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Jaros\u0142aw Oleszczuk",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 anonyme AbbVie, si\u00E9geant \u00E0 Wavre, a d\u00E9l\u00E9gu\u00E9 \u00E0 Fabienne Hanssens, directrice des ressources humaines, le pouvoir de signer tous documents relatifs \u00E0 l\u0027embauche, \u00E0 la r\u00E9tention, \u00E0 la r\u00E9vocation, aux salaires et aux avantages sociaux de tous les employ\u00E9s de la soci\u00E9t\u00E9, y compris les int\u00E9rimaires et les consultants. Ce pouvoir est effectif \u00E0 compter de la date de la r\u00E9union du conseil, le 22 mai 2015.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Val\u00E9rie Buyse",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-04-17",
      "evidence_quote": "Les Actionnaires confirment la r\u00E9vocation avec effet au 17 avril 2015 du mandat de Mme. Val\u00E9rie Buyse en tant qu\u0027Administrateur de la Soci\u00E9t\u00E9."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jean Louis Gantmacher",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2015-05-11",
      "evidence_quote": "Les Actionnaires d\u00E9c\u00EDdent de nommer M. Jean Louis Gantmacher, de nationalit\u00E9 fran\u00E7aise, r\u00E9sidant 7 rue Raye Tortue, 92350 Le Plessis Robinson, France, en tant qu\u0027Administrateur de la Soci\u00E9t\u00E9, avec effet \u00E0 la date des pr\u00E9sentes r\u00E9solutions"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Bouyer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2014-12-01",
      "evidence_quote": "Le Conseil d\u0027Administration prend note de et accepte, pour autant que de besoin, la d\u00E9mission de M. J\u00E9r\u00F4me Bouyer de ses fonctions d\u0027Administrateur D\u00E9l\u00E9gu\u00E9 et de Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9, prenant effet au 1er d\u00E9cembre 2014."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Jaroslaw Oleszczuk",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2014-12-01",
      "evidence_quote": "Le Conseil d\u0027Administration confirme par cons\u00E9quent que M. J\u00E9r\u00F4me Bouyer est remplac\u00E9 par M. Jaroslaw Oleszczuk, de nationalit\u00E9 polonaise, r\u00E9sidant Val du Prince 6, B-1950 Kraainem, en qualit\u00E9 d\u0027Administrateur D\u00E9l\u00E9gu\u00E9 et de Pr\u00E9sident du Conseil d\u0027Administration de la Soci\u00E9t\u00E9, avec effet au 1er d\u00E9cem"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jaroslaw Oleszczuk",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2014-12-01",
      "evidence_quote": "Les Actionnaires d\u00E9cident de confirmer la nomination de M. Jaroslaw Oleszczuk, de nationalit\u00E9 polonaise, r\u00E9sidant Val du Prince 6, B-1950 Kraainem, en tant qu\u0027Administrateur de la Soci\u00E9t\u00E9, avec effet au 1er d\u00E9cembre 2014 pour un terme prenant fin lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnair"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 33000000.0,
      "currency": "EUR",
      "after_eur": 126988345.1,
      "delta_eur": -33000000.0,
      "before_eur": 159988345.1,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2014-08-12",
      "evidence_quote": "de r\u00E9duire le capital social \u00E0 concurrence de trente-trois millions d\u0027euros (33.000.000,00 EUR), pour le ramener de cent cinquante-neuf millions neuf cent quatre-vingt-huit mille trois cent quarante-cinq euros dix cents (159.988.345,10 EUR) \u00E0 cent vingt-six millions neuf cent quatre-vingt-huit mille trois cent quarante-cing euros dix cents (126.988.345,10 EUR).",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0845.096.860",
    "name_full": "ABBVIE",
    "legal_form": "SA"
  }
}